IRIDEX stock gained 7.28 percent after factory move
Published on 10/06/2026 at 12:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
IRIDEX (US4626841013) stock closed at USD 0.69 on Nasdaq on October 5, 2026, up 7.28 percent from USD 0.64. The company completed its manufacturing relocation from Mountain View to San Jose, with annualized savings of USD 0.6 million targeted under its cost-reduction plan, as GlobeNewswire reported on October 5, 2026.
Factory move targets USD 0.6 million
The relocation is designed to reduce operating costs and improve manufacturing efficiency. IRIDEX said the savings target is consistent with its earlier expectations, while further savings opportunities may emerge as the transition becomes fully integrated, according to GlobeNewswire.
The move matters because the company entered the latest quarter with a mixed operating profile. The relocation can lower the cost base, but execution remains important while IRIDEX manages supply-chain and regulatory transitions in international markets.
Q2 revenue fell 7 percent
For the quarter ended July 4, 2026, total revenue was USD 12.6 million, down 7 percent from USD 13.6 million a year earlier. Net loss widened to USD 1.3 million, or USD 0.07 per share, from USD 1.0 million, or USD 0.06 per share, in the prior-year quarter, according to The Globe and Mail on August 18, 2026.
The brighter counterpoint was the glaucoma franchise. Cyclo G6 probe volume reached 17,700 units, up 35 percent from 13,100 units, while Cyclo G6 product-family revenue increased 19 percent to USD 3.9 million. Full-year 2026 revenue guidance remained USD 51 million to USD 53 million, excluding Middle East revenue, the earnings-call transcript said.
Consensus target stays above USD 2.75
One analyst covers IRIX with a moderatebuy consensus and an average price target of USD 2.75, according to Rallies as of September 15, 2026. That target lies 298.6 percent above the October 5 closing price of USD 0.69, making the estimate highly sensitive to execution and liquidity.
IRIDEX stock closes at USD 0.69
IRIDEX stock closed at USD 0.69 on Nasdaq on October 5, 2026, with a 52-week range of USD 0.61 to USD 1.65, volume of 136,442 shares and a market capitalization of USD 11.9 million. The close was 58.2 percent below the 52-week high, leaving the factory savings plan and the recovery in glaucoma demand as key operating markers.
IRIDEX stock key facts
- Company: IRIDEX Corporation
- ISIN: US4626841013
- Ticker: IRIX
- Trading venue: Nasdaq
- Price (as of October 5, 2026, 4:00 p.m. ET): USD 0.69 Closing price (October 5, 2026)
- Market capitalization: USD 11.9 million (as of October 5, 2026)
- 52-week range: USD 0.61-1.65 (as of October 5, 2026)
- Sector / Industry: Healthcare / Medical Devices
